Search: 2019 EU Faculty
Results 21 - 35 of 35

Jane Nunn

Head of Operations
Complete HealthVizion

Type of Company:
Communications Agency
Professional Degrees: CMPP, PhD
CMPP Certified: (2/2009)

Bio: Jane is Head of Operations at Complete HealthVizion, and through her 20 years in the industry has amassed extensive experience of all areas of publication planning and management. She has advised clients on the planning and delivering of publication plans across numerous therapeutic areas, at all stages of a product life cycle and at global, regional and local levels. She is passionate about innovations in publication planning and has been integral in the development of innovative digital tools to assist publication professionals. Jane acts as executive advisor to her global team on all aspects of publication planning and compliance, and has partnered with clients to deliver their own policies and procedures. She has been an active member of ISMPP for many years having previously served as Chair of the ISMPP European Programme Committee, acted as faculty at both the European and Annual meetings and authored articles / posters on current publication-related topics. She is a Certified Medical Publication Professional and has helped train dozens of staff over the years to become recognized publication professionals.

Valerie Philippon

Head, Publications, Global Medical Affairs
Shire, now part of Takeda

Type of Company:
Pharmaceutical
Professional Degrees: PhD

Bio: Valerie Philippon is the Head of Global Publications at Shire, now a part of Takeda, a leading global biotech in rare diseases with medicines in over 100 countries. She leads the publications teams responsible for publications related to all company therapeutic areas (hematology, immunology, gastrointestinal/internal medicine, neuroscience, ophthalmics, genetic diseases) across various geographies. Valrie has over 20 years of experience in Research, Development, and Medical Communications. She received her Ph.D. in Microbiology from the University Denis Diderot Paris, France and completed a post-doctoral fellowship at Harvard School of Public Health. She has held various Publications and Scientific Communication roles with increasing responsibilities at Idenix, Vertex, AVEO Oncology, and Cubist before joining Shire.

Andy Powrie-Smith

Director of Communications
EFPIA

Bio: Mr. Powrie-Smith joined EFPIA in 2015, and has been responsible for the creation and delivery of EFPIA's communication strategy. He has also served as Co-chair of the EFPIA Patient Think Tank and Chair of the EFPIA Communications Network. Prior to EFPIA, Mr. Powrie-Smith worked at the Association of the British Pharmaceutical Industry (ABPI), serving as Director of ABPI Scotland and managing ABPI's Reputation Strategy group.

Nicole Rapior

Global Head Medical Communications, Medical Affairs Operations
Boehringer Ingelheim International GmbH

Type of Company:
Pharmaceutical
Professional Degrees: MS, PhD

Bio: Nicole heads Global Medical Communications at Boehringer Ingelheim since summer 2018 after having headed the Global Scientific Communications Team from 2012 to 2018. Global Medical Communications is responsible for Medical Information and Medical Publications. This includes the planning and development of all global scientific publications for Boehringer Ingelheim's main therapeutic areas, respiratory, cardiovascular and metabolic diseases as well as oncology, immunology and CNS. In total, she has over 10 years of experience within the field of scientific publications having also worked as Global Publications Strategy Manager in prior roles at Boehringer Ingelheim, Warner Chilcott Pharmaceuticals and Procter & Gamble Pharmaceuticals. Nicole holds a Ph.D. in Biochemistry and a Master degree in Advanced Oncology.

Tom Rees

Communications Director
Oxford PharmaGenesis

Type of Company:
Communications Agency
Professional Degrees: BA/BS, MS, PhD
CMPP Certified: 3/2015

Bio: Tom has over 20 years' experience in medical communications and publications planning, and is currently a Communications Director at Oxford PharmaGenesis, having previously held roles in strategic consultancy, as a team leader and lead medical writer. Tom is a regular contributor to the US and European ISMPP meetings, and has delivered a number of workshops and new research presentations on the topics of publications innovations, good publications practice, and patient communications, publication metrics (including altmetrics), and social media. He currently serves on the ISMPP Social Media/Web-based Metrics Working Group and is a past member of the ISMPP Credentialing and Global Workshop Committees. Tom holds a PhD in Biotechnology from Cranfield University in the UK, and is CMPP certified.

Jan Seal-Roberts

Publishing Director
Adis, Springer Healthcare

Type of Company:
Publisher
Professional Degrees: BA/BS

Bio: Jan Seal-Roberts is a medical publisher with more than 20 years' experience, and has worked with several global companies including Blackwell Science (now part of Wiley), Wolters Kluwer and Springer Nature. Jan is currently Publishing Director for Adis (part of Springer Healthcare) which publishes 33 journals exclusively in the area of drugs and disease management.

Gavin Sharrock

Senior Director, Operations & Business Development, Corporate Solutions
Wiley

Type of Company:
Publisher
Professional Degrees: CMPP
CMPP Certified: (9/2015)

Bio: Gavin Sharrock, Senior Director, Operations and Business Development, Corporate Solutions, Wiley Gavin started his career at Wiley (formerly Blackwell Publishing) as a Production Editor in Content Management, before moving on to become a Journal Publishing Manager and then a Publisher in Editorial, and then moving into business development in a Business Innovations group. Gavin has worked at Wiley for over 20 years and has considerable experience in working with medical societies and corporate clients, particularly in the Pharma and medical device industries. He currently works in the Corporate Solutions team and is responsible for working with societies and industry to generate more revenue from industry, principally although not exclusively through their publications. This includes looking at new content-driven products and services for corporate clients, as well as making sure that the partnerships that we facilitate between industry and societies promote and strengthen the brand of the journal and society and provide value to the end users.

Chris Skedgel

Senior Consultant
IQVIA

Bio: Chris has over 20 years of applied health economics experience in academia and, more recently, with IQVIA, a large multinational consultancy. He is interested in the use of health economics in maximising the societal value of limited healthcare resources. This includes evaluating value-for-money in terms of cost per quality-adjusted life year (QALY) gained, as well as broader concepts based on patient and public values derived using stated preference methods. He has more than 50 peer-reviewed publications on topics including cost-effectiveness evaluations, preference studies, methodological contributions and invited editorials. He sits on the editorial board of Pharmacoeconomics and maintains a link to academia as an Honorary Senior Research Fellow at the University of East Anglia. He has been a Lead Economic Reviewer for the pan-Canadian Oncology Drug Review (pCODR) and the Canadian Common Drug Review (CDR). Chris has a PhD in Health Economics & Decision Science from The University of Sheffield and a masters degree in Development Economics from Dalhousie University, Canada.

Stuart Spencer

Sr. Executive Editor
The Lancet

Bio: For the past 20 years Stuart has led the Lancet's Fast Track team that aims to select, review and publish prestigious manuscripts within 4 weeks of receipt. Although dealing with all areas of research, he deals with most of the cardiology submissions. Stuart started his research at the Brompton Hospital, London, looking at scoliosis in children before moving to the Veterinary School site at Bristol University. Later he set up a research team for a major pharmaceutical company in Switzerland for a year, and then spent 9 years as a senior researcher in New Zealand. He has also worked in the Netherlands, had two senior research fellowships at Leuven University, Belgium, and visiting professorships at Kings College, London and Hong Kong University, and a doctorate of medicine from Umea University, Sweden. Stuarts research expertise includes such diverse topics as, growth, neuroendocrinology, immunology and fetal development. He also had a Senior Fellowship in bioethics for 5 years. Stuart is also a Trustee of the Scoliosis Association (UK), board member of British Scoliosis Research Fund and the Steering Committee of the Swedish National GP Research School.

Simon Stones

Patient Advocate and Consultant

Bio: Simon Stones is an award-winning patient leader, advocate, speaker and consultant, who was the winner of the international WEGO Health Award for Patient Healthcare Collaborator in 2017. Simon was diagnosed with arthritis, inflammatory bowel disease and fibromyalgia during his childhood, and also supports his parents who have a significant amount of chronic health conditions. Together, these experiences have stimulated Simon's interest in healthcare, driving him to improve the health and wellbeing of people with chronic health conditions. He is currently a PhD Candidate at the University of Leeds, where he is developing a framework to improve the supported self-management of arthritis by children and their families. Simon is also an active patient research partner on various national and international research projects and initiatives, and is a board member of four associations: the European Network of Arthritis in Children (ENCA), the European Network of Fibromyalgia Associations (ENFA), Fibromyalgia Action UK and RAiISE Invisible illnesses in schools and education.

David Sweeney

Executive Chair
Research England

Bio: After gaining First Class Honours in Statistics at the University of Aberdeen, David worked at two BBSRC research institutes, as a consultant statistician before developing mathematical models of plant growth. His work on the computational aspects of this led into broader applications of IT in education and research, and he was Director of Information Services at Royal Holloway, University of London, before moving into university leadership as Vice-Principal (Communications, Enterprise and Research) in 2004. In this role he was responsible for research strategy and for developing Royal Holloway's research-led commercial and consultancy activities. He joined HEFCE in 2008 as Director (Research, Innovation and Skills) and led the development and implementation of the first Research Excellence Framework including the new impact agenda element. He was responsible for research policy and funding, knowledge exchange and university/business relations. In May 2017 he was appointed the first Executive Chair of Research England, a new council established as part of UK Research and Innovation, alongside the seven disciplinary Research Councils and the UK Innovation Agency. Research England is biggest research funder in the UK with responsibility for university block-grant funding for research and knowledge exchange. In UKRI he has particular responsibilities for Place (Regional Funding), Commercialisation and Open Science David has been invited to visit many countries to advise on research assessment and funding, particularly with respect to research impact. He is also co-chair of the Implementation Task Force for Plan S, the international initiative on full and immediate open access to research publications. David was awarded an honorary doctorate from the University of Aberdeen in 2012, was Vice-Chancellors Fellow at the University of Newcastle, NSW in 2015 and is a Fellow of the Royal Statistical Society.

Anne Clare Wadsworth

Global Business Unit Head
Envision Pharma

Bio: Anne Clare brings a wealth of experience in healthcare communications from a 20 year career leading medical strategy and communication agencies. With a focus on innovation, Anne Clare has been at the forefront of transforming agency services, reflecting the ever-changing requirements of Medical Affairs and Publications teams within biopharmaceutical companies. Beginning her agency career at Gardiner-Caldwell Communications in 2000, Anne Clare supported clients across multiple therapy areas and product launches prior to joining Envision Pharma Group in 2016 as part of the senior leadership team. With a keen interest in patient engagement, Anne Clare has been a vocal advocate for tackling the lack of consistent and evidence-based practices for patient partnership within life science communications as well as exploring how patient advocates and medical affairs teams can work in partnership towards shared goals. Last year, Anne Clare in partnership with her colleague Professor Karen Woolley, launched a new centre of excellence within Envision Pharma Group dedicated to Patient Partnership in Medical Affairs and Publications. Comprising a team of industry experts, the Envision the Patient team are leading the industry debate on the removal of barriers for patients wanting access to high quality, fair-balance scientific content.

Al Weigel

President/CEO
ISMPP

Type of Company:
Other
Professional Degrees: CMPP, MEd
CMPP Certified: (2/2009)

Bio: Al Weigel is President and COO for the International Society for Medical Publication Professionals (ISMPP). Al joined ISMPP in November of 2013 with primary responsibility for implementing the strategic goals and vision of the Society, in addition to ensuring the Society meets established milestones for ongoing development, growth and success. Prior to joining ISMPP, Al led cross-therapeutic medical publication and scientific communication teams at sanofi-aventis, Boehringer-Ingelheim and Celgene Corporation. Al earned his Masters of Education at the University of the Arizona and currently is a ISMPP Certified Medical Publication Professional (CMPP).

Christopher Winchester

Chief Executive Officer
Oxford PharmaGenesis

Type of Company:
Communications Agency
Professional Degrees: BA/BS, PhD

Bio: Chris Winchester is Chief Executive Officer of Oxford PharmaGenesis, an independent HealthScience communications consultancy with a strong heritage in publications. Now in its 21st year, Oxford PharmaGenesis employs over 250 communications professionals in Europe, North America and Asia Pacific. Chris is Chair of ISMPP, a founder of Open Pharma, led the development of the AMWA-EMWA-ISMPP Joint Position Statement on the role of the professional medical writer, and has been involved in collaborative research on the value of professional medical writing support. He has a doctorate in Biochemistry, has co-authored articles in the fields of cardiology, gastroenterology and respiratory medicine, and is an Associate Member of Green Templeton College at the University of Oxford.

Robert Wright

Head, Clinical Data Transparency, Medical Governance and Ethics - CMO
Sanofi

Type of Company:
Pharmaceutical
Professional Degrees: PharmD

Bio: Bob graduated with a Doctor of Pharmacy (PharmD) degree from the University of Texas at Austin College of Pharmacy. He is currently the Head of Clinical Data Transparency in the Chief Medical Officer's Office at Sanofi. He and his team lead the company-wide policies and systems for publications and data sharing. Prior to joining Sanofi, he held a variety of US and Global medical affairs positions at Bristol-Myers Squibb and Astra Zeneca. In his 20 years of experience in the pharmaceutical industry, he has led several high priority brands across multiple therapeutic areas, including oncology, cardiovascular, and diabetes.
<< first < Prev 1 2 Next > last >>